Nuclear magnetic resonance

TreeHouse Foods, Inc. Announces COO Transition

Retrieved on: 
Wednesday, April 14, 2021
Oak Brook, Illinois, TreeHouse Foods, Nuclear magnetic resonance, Treehouse, Food, Companies, Science and technology

In the interim, Mr. Braun\'s responsibilities will be assumed by Craig McCutcheon, currently Senior Vice President, Operations.\nMr.

Key Points: 
  • In the interim, Mr. Braun\'s responsibilities will be assumed by Craig McCutcheon, currently Senior Vice President, Operations.\nMr.
  • McCutcheonjoined TreeHouse in 2018 and oversees TreeHouse\'s manufacturing and warehousing operations.
  • "\nTreeHouse Foods, Inc. is a leading manufacturer and distributor of private label packaged foods and beverages in North America.
  • Such statements reflect our current views with respect to future events and are subject to certain risks, uncertainties, and assumptions.

Jacques Esculier Joins Loop Energy's Advisory Council

Retrieved on: 
Monday, April 12, 2021
Energy, Hydrogen economy, Hydrogen technologies, Articles, Science and technology, Energy storage, Sustainable technologies, Pentair, IHS Markit, Nuclear magnetic resonance, Fuel cell, Hydrogen vehicle

b'VANCOUVER,BC, April 12, 2021 /PRNewswire/ - Loop Energy (TSX: LPEN), a developer and manufacturer of hydrogen fuel cell-based solutions, announces the addition of Jacques Esculier to the company\'s advisory council.

Key Points: 
  • b'VANCOUVER,BC, April 12, 2021 /PRNewswire/ - Loop Energy (TSX: LPEN), a developer and manufacturer of hydrogen fuel cell-based solutions, announces the addition of Jacques Esculier to the company\'s advisory council.
  • Mr. Esculier also served on the board of directors of Pentair PLC until May 2020.\n"I am very pleased to support Loop\'s commercialization strategy, offering a unique counsel position during this stage of rapid development for the company," said Jacques Esculier.
  • "We are very excited that Jacques has chosen to work with Loop to help us establish our global footprint in the commercial automotive supply chain."\nMr.
  • Esculier joins Loop Energy\'s advisory council along with two other recently appointed members, Lord John Browne and Lance Uggla.

Jacques Esculier Joins Loop Energy's Advisory Council

Retrieved on: 
Monday, April 12, 2021
Loop, Fusi, Nuclear magnetic resonance

b'VANCOUVER,BC, April 12, 2021 /PRNewswire/ -- Loop Energy (TSX: LPEN), a developer and manufacturer of hydrogen fuel cell-based solutions, announces the addition of Jacques Esculier to the company\'s advisory council.

Key Points: 
  • b'VANCOUVER,BC, April 12, 2021 /PRNewswire/ -- Loop Energy (TSX: LPEN), a developer and manufacturer of hydrogen fuel cell-based solutions, announces the addition of Jacques Esculier to the company\'s advisory council.
  • "We are very excited that Jacques has chosen to work with Loop to help us establish our global footprint in the commercial automotive supply chain."\nMr.
  • Esculier joins Loop Energy\'s advisory council along with two other recently appointed members, Lord John Browne and Lance Uggla.
  • Loop disclaims any obligation to update these forward-looking statements.\nLoop Energy Media Contact: Ashley Eisner | Tel: +1.212.697.2600 | [email protected] ; Loop Energy Business Contact: George Rubin, CCO | Tel: +1.604.828.8185 | [email protected] ; Loop Energy EMEA Contact: Luigi Fusi | +39.028457.3048 | [email protected]\n'

Purity-IQ Contributes $1,000,000 to NHP Research Alliance at the University of Guelph

Retrieved on: 
Monday, April 12, 2021
Analytical chemistry, Bruker, Nuclear magnetic resonance, AOAC International, Authentication, Toyota iQ, Science and technology, Science, Technology

We too are driven by, and firmly believe in, the need for authenticity, identity and purity of products and ingredients.

Key Points: 
  • We too are driven by, and firmly believe in, the need for authenticity, identity and purity of products and ingredients.
  • "Recent investments by Purity-IQ of over $1.25 Million in Bruker NMR spectroscopy has greatly expanded the R&D capacity, at the NHPRA.
  • It embraces cutting edge molecular diagnostic methods to develop standards for authentication of ingredients, with options for certification using consumer trust marks.
  • Together they create new, consensus-based standards verified by AOAC, USP, FDA and Health Canada.\nView original content to download multimedia: http://www.prnewswire.com/news-releases/purity-iq-contributes-1-000-000-...\n'

ABLIC Launches the "S-5701 B Series" a TMR Sensor IC That Solves Reed Switch Limitations With Durable, Small and Long-life Features

Retrieved on: 
Wednesday, March 31, 2021
Semiconductor, Utilities, Technology, Manufacturing, Energy, Other Manufacturing, Hardware, Sensors, Electromagnetism, Fictional characters, Equipment, Magnetometer, Nuclear magnetic resonance, Magneto, Transducers, Current sensing

ABLIC Inc. (President: Nobumasa Ishiai, head office: Minato-ku, Tokyo, hereinafter ABLIC) today launched the S-5701 B Series surface mount TMR (Tunnel Magneto Resistance) sensor IC, a magnetic sensor IC with super-low current consumption, high magnetic sensitivity, long life and an operating current consumption of a mere 160nA.

Key Points: 
  • ABLIC Inc. (President: Nobumasa Ishiai, head office: Minato-ku, Tokyo, hereinafter ABLIC) today launched the S-5701 B Series surface mount TMR (Tunnel Magneto Resistance) sensor IC, a magnetic sensor IC with super-low current consumption, high magnetic sensitivity, long life and an operating current consumption of a mere 160nA.
  • View the full release here: https://www.businesswire.com/news/home/20210330005465/en/
    The S-5701 B Series is a TMR sensor IC.
  • However, unlike other MR sensor ICs such as Anisotropic Magneto Resistive (AMR) or Giant Magneto Resistive (GMR) sensor ICs, it features high sensitivity and super-low current consumption (160nA) making it an innovative product that solves the limitations of a conventional reed switch.
  • About 1/6th of the current consumption of a regular AMR IC

Cambridge Isotope Laboratories, Inc and Bruker Biospin Announce Strategic Partnership for the Global Distribution of CIL's NMR Solvents

Retrieved on: 
Monday, March 29, 2021
Bruker, Nuclear magnetic resonance, Science, Economic taxonomy

Cambridge Isotope Laboratories, Inc. (CIL) is entering a global, strategic partnership with Bruker BioSpin for the distribution of CIL's NMR Solvents

Key Points: 
  • In tandem, both CIL and Bruker products are utilized in analytical laboratories, medical, government and academic research centers worldwide.
  • Together, these instrument platforms and consumable products have contributed to groundbreaking new-drug development, environmental analysis, diagnostic research and countless medical advancements.
  • This agreement will allow Bruker to sell CIL NMR Solvents through their global sales channels as well as the Bruker Labscape Webshop, ( https://bruker-labscape.store ).
  • CIL will increase their global footprint for NMR solvents by adding a new sales channel and allow Bruker to offer full after-market care, extending customer service throughout the product lifecycle.

Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs

Retrieved on: 
Friday, March 26, 2021
Research, Technology, Medical devices, Nanotechnology, Software, Biotechnology, Hardware, Health, Data management, Science, Physical sciences, Natural sciences, Academic disciplines, Nuclear magnetic resonance, Bruker, Electron paramagnetic resonance, Spectroscopy, Benchtop nuclear magnetic resonance spectrometer, Electron magnetic resonance

Just prior to the 2021 Experimental Nuclear Magnetic Resonance Conference ( www.enc-conference.org ), Bruker Corporation (Nasdaq: BRKR) is making chemical analysis by magnetic resonance spectroscopy more broadly accessible beyond the central lab.

Key Points: 
  • Just prior to the 2021 Experimental Nuclear Magnetic Resonance Conference ( www.enc-conference.org ), Bruker Corporation (Nasdaq: BRKR) is making chemical analysis by magnetic resonance spectroscopy more broadly accessible beyond the central lab.
  • Brukers new magnetic resonance systems are intended for pharma, chemical and food research and analysis, as well as for teaching and chemistry research in any academic lab, university department or college.
  • The Fourier 80, together with the AvanceCore 400 , an affordable 400 MHz NMR, plus the versatile Bruker Magnettech ESR 5000 benchtop EPR (Electron Paramagnetic Resonance) broaden the magnetic resonance analytical solutions for academic, pharma and chemical industry - beyond central labs.
  • The latest developments include a heteronuclear 1H/31P configuration for food analysis, biological or medicinal research applications, organometallic chemistry and more.

numares announces FDA 510(k) Submission of AXINON System®, a NMR platform for metabolomics-based, AI-driven Diagnostics

Retrieved on: 
Wednesday, March 24, 2021
Hardware, FDA, Other Health, Technology, Finance, Professional services, Medical devices, Venture capital, Cardiology, Science, Biotechnology, Software, Other Science, Health, Research, Metabolism, Branches of biology, Metabolomics, Omics, Systems biology, IVD, Nuclear magnetic resonance, Biology, Academic disciplines

Leading NMR diagnostics company numares AG today announced that the company made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its AXINON IVD System, a NMR-platform for AI-driven, metabolomics-based diagnostics.

Key Points: 
  • Leading NMR diagnostics company numares AG today announced that the company made a 510(k) submission to the U.S. Food and Drug Administration (FDA) for its AXINON IVD System, a NMR-platform for AI-driven, metabolomics-based diagnostics.
  • Several multi-marker assays for AXINON will cover numerous unmet medical needs, in order to prevent, diagnose and treat disease.
  • View the full release here: https://www.businesswire.com/news/home/20210324005057/en/
    numares AXINON IVD System: The AI-driven AXINON Software, in combination with advanced NMR technology, refined by numares' proprietary Magnetic Group SignalingTM, allows metabolomics-based precision diagnostics by implementation of various numares' tests, e.g.
  • "This U.S. regulatory filing for its diagnostics platform is an important milestone for numares," said Winton Gibbons, President - US and co-Chief Executive Officer of numares.

FenixOro Establishes Preliminary Target of 1.6 – 2.4 Million Ounces at Abriaqui Following Analysis of Phase 1 Drill Results

Retrieved on: 
Friday, March 19, 2021
Science and technology, Magnetometer, Nuclear magnetic resonance, Sensors, Equipment, Oil well, Technology

On these four veins alone there is an estimated 1.6 -2.4 million ounce minimum resource potential down to the 1500 meter elevation.

Key Points: 
  • On these four veins alone there is an estimated 1.6 -2.4 million ounce minimum resource potential down to the 1500 meter elevation.
  • Given these factors, FenixOro considers the clearly defined 1.6 2.4 million ounce target to represent a minimum objective of future exploration and definition drilling.
  • The analysis of Phase 1 drill results is intended to estimate the potential for future resources which will require significant additional drilling to define.
  • A Phase 1 drilling program has begun at Abriaqui following the completion of surface and underground geological mapping and sampling, as well as a preliminary magnetometry survey.

CuraSen Therapeutics Announces Phase 1 Clinical Data Demonstrating that Salbutamol, a Beta-2 Adrenoceptor Agonist, Significantly Increases Cerebral Perfusion, a Key Marker in Neurodegenerative Disease

Retrieved on: 
Monday, March 15, 2021
General Health, Infectious diseases, Other Health, Health, Pharmaceutical, Branches of biology, Biology, Psychiatric diagnosis, Magnetic resonance imaging, Neuroimaging, Arterial spin labelling, Imaging, Nuclear magnetic resonance, Perfusion, Parkinson's disease, Alzheimer's disease

Reductions in regional cerebral perfusion are an early sign of Alzheimers and other neurodegenerative diseases, and are associated with reduced cognition, attention and mood.

Key Points: 
  • Reductions in regional cerebral perfusion are an early sign of Alzheimers and other neurodegenerative diseases, and are associated with reduced cognition, attention and mood.
  • Magnetic resonance imaging with arterial spin labeling (ASL), a non-invasive technique for monitoring brain perfusion, was undertaken before and after administration of salbutamol.
  • CuraSen is focused on the development of new treatments for a variety of neurodegenerative diseases, including Parkinsons disease, Alzheimers disease and other related orphan conditions.
  • The company is currently evaluating CST-2032, its first proprietary compound intended for the treatment of neurodegenerative disease, in a multi-part, Phase 1 clinical study.